Moving Us Forward
We’ll see you in St. Louis, MO, USA, for the annual Cancer Genomics Consortium! The CGC Annual Meeting is a unique gathering aimed at bringing the clinical genomics community together to create an environment of collaboration, education and networking. With the continuing and evolving partnerships between cytogeneticists, molecular geneticists, pathologists, oncologists, and bioinformaticians, CGC is committed to playing an essential role in providing guidance on the best practice of genomic testing. Bionano attends as we are committed to elevating human health by genomic research.
Learn
Please join us for our corporate sponsored session where scientific experts will participate in a live interactive panel discussion on work towards ‘Unleashing Genomic Insights That Matter with Optical Genome Mapping’ (OGM).
SPONSORED SESSION
Unleashing Genomic Insights That Matter with Optical Genomic Mapping: An Interactive Panel Discussion
-
Monday, August 14, 2023
-
12:30 – 1:00 PM (CDT)
-
General Session Room – Grand Ballroom EF (on the 4th floor)
This live and interactive panel discussion, moderated by Bionano’s Chief Medical Officer, Alka Chaubey, will feature four key cancer genomic experts. Experts will discuss their experience with OGM, key applications and fit within the genomics toolbox, implications to future clinical research and medical guidelines, operational efficiencies, as well as recommendations for proper implementation of the method by laboratories.
Moderator:
- Alka Chaubey, PhD, FACMG | Chief Medical Officer, Bionano
Presenters:
- Ravindra Kolhe, MD, PhD, FCAP | Augusta University (Georgia, USA)
- Yassmine Akkari, PhD, FACMG | Nationwide Children’s Hospital (Ohio, USA)
- Susan Crocker, PhD, FCCMG | Kingston Health Sciences Centre/Kingston General Hospital Site, Queen’s University (Ontario, Canada)
- Sachin Jadhav, MD | Head of Hematology and Stem Cell Transplantation, HCG Network (Bengaluru, India)
Alka Chaubey, PhD, FACMG
Ravindra Kolhe, MD, PhD, FCAP
Yassmine Akkari, PhD, FACMG
Susan Crocker, PhD, FCCMG
Sachin Jadhav, MD
Don’t miss the latest research at the Poster Sessions!
Poster SessionsConnect
If you’re curious about optical genome mapping (OGM) and wondering how it connects to your work, stop by and talk to one of our dedicated team members. We can’t wait to share our enthusiasm for this technology that is moving clinical research forward in remarkable ways.
Booth #14/15
Visit the Bionano booth #14/15 to check out our Saphyr system and ask how our newest products in our nucleic acid purification and analysis software portfolios create a solution-based OGM workflow. Stop by the booth to talk to our OGM specialists and ask questions about how your current workflow can be elevated with Bionano’s solutions and OGM workflow.
Network
If we want to change the way the world sees the genome, we must move forward together. Enjoy some time with colleagues outside the conference center, exchange resources and ideas, and have some fun!
Networking Event
-
Monday, August 14, 2023
-
8:00 – 11:00 PM
-
Gateway Terrace
(Hyatt Regency St. Louis at the Arch)
We welcome you to join our social networking event to celebrate YOU, “The Stars of Genomics”! We can’t wait to spend time with you and continue our conversations about how the OGM workflow can support your research initiatives.
Poster Sessions
Three posters featuring results from OGM applications in cytogenetics and cancer research will be presented at the conference. Scientific presentations from Bionano and collaborators include:
-
August 13, 2023 | 2:15-3:15 PM CDT
-
August 14, 2023 | 11:45 AM-12:15 PM CDT
-
August 15, 2023 | 2:00-3:00 CDT
| POSTER | TITLE | LEAD AUTHOR |
|---|---|---|
| Session 1 August 13, 2023, 2:15-3:15 PM CDT |
Applications of Emerging Technologies in Clinical Genomics Application of optical genome mapping to identify samples with homologous recombination deficiency | A. Hastie |
| Session 2 August 14, 2023, 11:45 AM-12:15 PM CDT |
Speed Abstracts Analytical validation of an optical genome mapping assay for the detection of structural variation in hematologic malignancies as a lab-developed test | T. Sahoo |
| Session 9 August 15, 2023, 2:00-3:00 CDT |
Applications of Emerging Technologies in Clinical Genomics A novel method for detection of loss of heterozygosity using B-allele frequency from optical genome mapping data | A. Raksi |
| Atypical BCR-ABL1 rearrangements identified by optical genome mapping in patients with chronic myeloid leukemia | Sahoo, T. | |
| Optical genome mapping for detection of biomarkers in residual disease monitoring research of hematologic malignancies | Yu, J. |
